SERT/NET-IN-1
SERT/NET-IN-1 is a blood-brain barrier-permeable SERT and NET inhibitor, with an IC50 of 11.2 nM against human SERT and an IC50 of 32.0 nM against human NET. SERT/NET-IN-1 blocks 5-HT reuptake to enhance serotonergic signaling. SERT/NET-IN-1 also blocks norepinephrine reuptake to enhance central noradrenergic transmission and inhibits the ejaculatory reflex. SERT/NET-IN-1 prolongs ejaculatory latency, reduces ejaculation frequency and preserves sexual function. SERT/NET-IN-1 exhibits cross-species microsomal metabolic stability, shows acceptable oral brain exposure in rats, and has favorable safety profiles. SERT/NET-IN-1 can be used in studies related to premature ejaculation.
For research use only. We do not sell to patients.
- Formula: C16H20N2OS
- Molecular Weight:288.41
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biological Activity
-
Chemical Information
- Purity & Documentation
- References
-
Help & FAQs
All 5-HT Receptor Isoforms
More
Biological Activity
SERT/NET-IN-1 (compound 7) (1 μM; 0, 5, 15, 30, 60 min) exhibits excellent metabolic stability in human, mouse, rat, dog and monkey liver microsomes. The proportion of remaining parent compound ranges from 86.1% (rat) to 103% (dog) after 60 min, with 98.5% remaining in human liver microsomes[1].
SERT/NET-IN-1 (100 μM; 48 h) shows no obvious cytotoxicity in either HEK293 or HepG2 cells, with an IC50 of >100 μM in both cell lines[1].
SERT/NET-IN-1 (100 μM; 48 h) exhibits almost no agonistic activity on μ-opioid receptors, with an EC50 > 100 μM[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:HEK293, HepG2 cell
-
Concentration:0-100 μM
-
Incubation Time:48 h
-
Result:Showed no obvious cytotoxicity in either HEK293 or HepG2 cells, with an IC50 of > 100 μM in both cell lines.
SERT/NET-IN-1 (20 mg/kg; i.p.; single administration, tested 15 min post-dose) significantly prolongs the ejaculation latency period (from 223.3 s to 713.2 s) and reduces the number of ejaculations within 20 min (from 2.25 to 1.125) in the 8-OH-DPAT-induced premature ejaculation model of male Wistar rats[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Male Wistar rats (10 weeks old, trained for 4 weeks to establish stable sexual behavior); premature ejaculation model induced by intraperitoneal injection of 0.4 mg/kg 8-OH-DPAT 1 h before testing[1]
-
Dosage:10 mg/kg and 20 mg/kg
-
Administration:intraperitoneal injection 15 min before testing
-
Result:At 10 mg/kg, showed no significant effect on ejaculation latency or the number of ejaculations.
At 20 mg/kg, significantly increased ejaculation latency from 223.3 s (pre-dose) to 713.2 s (post-dose) (p=0.0281) and reduced the number of ejaculations in 20 min from 2.25 to 1.125 (p=0.0313).
Had no significant effect on mount latency, intromission latency, post-ejaculatory interval, or copulatory rate, indicating no impairment of sexual motivation or erectile function.
Chemical Information
-
Molecular Weight 288.41
-
Formula C16H20N2OS
-
SMILES
CCC(N(C1CCNCC1)C2=C3C=CSC3=CC=C2)=O
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
SERT/NET-IN-1 Related Classifications
HY-182244 Related Classifications
Powered by Bioz